COVID-19 cancer conundrum—evidence driving decisions or the lack of it?

by Nalinie Joharatnam-Hogan, Khurum Khan
Published 2020-06-01

The role of aspirin in the prevention of ovarian, endometrial and cervical cancers

by Nalinie Joharatnam-Hogan, Fay H Cafferty, Archie Macnair, Alistair Ring, Ruth E Langley
Published 2020-10-01

Interpretation of DAS28 and its components in the assessment of inflammatory and non-inflammatory aspects of rheumatoid arthritis

by Daniel F. McWilliams, Patrick D. W. Kiely, Adam Young, Nalinie Joharatnam, Deborah Wilson, David A. Walsh
Published 2018-03-01

Multimodal Treatment in Metastatic Colorectal Cancer (mCRC) Improves Outcomes—The University College London Hospital (UCLH) Experience

by Nalinie Joharatnam-Hogan, William Wilson, Kai Keen Shiu, Giuseppe Kito Fusai, Brian Davidson, Daniel Hochhauser, John Bridgewater, Khurum Khan
Published 2020-11-01

Outcomes of the 2019 novel coronavirus in patients with or without a history of cancer: a multi-centre North London experience

by Nalinie Joharatnam-Hogan, Daniel Hochhauser, Kai-Keen Shiu, Hannah Rush, Valerie Crolley, William Wilson, Anand Sharma, Aun Muhammad, Muhammad Anwar, Nikhil Vasdev, Robert Goldstein, Ganna Kantser, Aramita Saha, Fharat Raja, John Bridgewater, Khurum Khan
Published 2020-09-01

COVID-19 in cancer patients on systemic anti-cancer therapies: outcomes from the CAPITOL (COVID-19 Cancer PatIenT Outcomes in North London) cohort study

by Valerie E. Crolley, Daire Hanna, Nalinie Joharatnam-Hogan, Neha Chopra, Ekin Bamac, Meera Desai, Yuk-Chun Lam, Sabiq Dipro, Ruhi Kanani, Jack Benson, William Wilson, Thomas A. Fox, Kai-Keen Shiu, Martin Forster, John Bridgewater, Daniel Hochhauser, Khurum Khan
Published 2020-10-01